companies developing glp-1 receptor agonists North America Glucagon-like Peptide-1 Strategies to Enhance the Therapeutic

Data Availability Statement The data are available upon request from the corresponding author

This article describes GLP-1 peptide characteristics and the mechanisms mediating its known role in increasing insulin, decreasing glucagon, delaying gastric emptying, and promoting satiety

Early findings also suggest potential benefits in systemic inflammation, kidney function, and metabolic syndrome

Abdominal injection absorbs fastest, thigh is slower with potentially fewer side effects, and the upper arm falls in between

Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial

Although it is less likely to get free GLP-1 medications, it is possible in certain cases